An ATM/Chk2-Mediated DNA Damage-Responsive Signaling Pathway Suppresses Epstein-Barr Virus Transformation of Primary Human B Cells

Abstract

Epstein-Barr virus (EBV), an oncogenic herpesvirus that causes human malignancies, infects and immortalizes primary human B cells in vitro into indefinitely proliferating lymphoblastoid cell lines, which represent a model for EBV-induced tumorigenesis. The immortalization efficiency is very low, suggesting that an innate tumor suppressor mechanism is operative. We identify the DNA damage response (DDR) as a major component of the underlying tumor suppressor mechanism. EBV-induced DDR activation was not due to lytic viral replication, nor did the DDR marks colocalize with latent episomes. Rather, a transient period of EBV-induced hyperproliferation correlated with DDR activation. Inhibition of the DDR kinases ATM and Chk2 markedly increased transformation efficiency of primary B cells. Further, the viral latent oncoprotein EBNA3C was required to attenuate the EBV-induced DDR. We propose that heightened oncogenic activity in early cell divisions activates a growth-suppressive DDR that is attenuated by viral latency products to induce cell immortalization.

References 51

1. 1.

   Alfieri C, Birkenbach M, Kieff E. Early events in Epstein-Barr virus infection of human B lymphocytes. Virology. 1991;181:595-608.

   Not in our library10.1016/0042-6822(91)90893-g (opens in a new tab)

2. 2.

   Anderton E, Yee J, Smith P, Crook T, White RE, Allday MJ. Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma. Oncogene. 2008;27:421-433.

   Not in our library10.1038/sj.onc.1210668 (opens in a new tab)

3. 3.

   Arienti KL, Brunmark A, Axe FU, McClure K, Lee A, Blevitt J, Neff DK, Huang L, Crawford S, Pandit CR, et al. Checkpoint kinase inhibitors: SAR and radioprotective properties of a series of 2-arylbenzimidazoles. J Med Chem. 2005;48:1873-1885.

   Not in our library10.1021/jm0495935 (opens in a new tab)

4. 4.

   Bartkova J, Horejsi Z, Koed K, Kramer A, Tort F, Zieger K, Guldberg P, Sehested M, Nesland JM, Lukas C, et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature. 2005;434:864-870.

   Not in our library10.1038/nature03482 (opens in a new tab)

5. 5.

   Bartkova J, Rezaei N, Liontos M, Karakaidos P, Kletsas D, Issaeva N, Vassiliou LV, Kolettas E, Niforou K, Zoumpourlis VC, et al. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature. 2006;444:633-637.

   Not in our library10.1038/nature05268 (opens in a new tab)

6. 6.

   Bild AH, Yao G, Chang JT, Wang Q, Potti A, Chasse D, Joshi MB, Harpole D, Lancaster JM, Berchuck A, et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature. 2006;439:353-357.

   Not in our library10.1038/nature04296 (opens in a new tab)

7. 7.

   Bridger JM, Lichter P, Bickmore WA. Analysis of mammalian interphase chromosomes by FISH and immunofluorescence. Chromosome Structural Analysis. 1999;103-121.

   Not in our library

8. 8.

   Chang JT, Nevins JR. GATHER: a systems approach to interpreting genomic signatures. Bioinformatics. 2006;22:2926-2933.

   Not in our library10.1093/bioinformatics/btl483 (opens in a new tab)

9. 9.

   Choudhuri T, Verma SC, Lan K, Murakami M, Robertson ES. The ATM/ATR signaling effector Chk2 is targeted by Epstein-Barr virus nuclear antigen 3C to release the G2/M cell cycle block. J Virol. 2007;81:6718-6730.

   Not in our library10.1128/jvi.00053-07 (opens in a new tab)

10. 10.

    Dahl J, You J, Benjamin TL. Induction and utilization of an ATM signaling pathway by polyomavirus. J Virol. 2005;79:13007-13017.

    Not in our library10.1128/jvi.79.20.13007-13017.2005 (opens in a new tab)

11. 11.

    Deng Z, Lezina L, Chen CJ, Shtivelband S, So W, Lieberman PM. Telomeric proteins regulate episomal maintenance of Epstein-Barr virus origin of plasmid replication. Mol Cell. 2002;9:493-503.

    Not in our library10.1016/s1097-2765(02)00476-8 (opens in a new tab)

12. 12.

    Dheekollu J, Deng Z, Wiedmer A, Weitzman MD, Lieberman PM. A role for MRE11, NBS1, and recombination junctions in replication and stable maintenance of EBV episomes. PLoS One. 2007;2:e1257.

    Not in our library10.1371/journal.pone.0001257 (opens in a new tab)

13. 13.

    Di Micco R, Fumagalli M, Cicalese A, Piccinin S, Gasparini P, Luise C, Schurra C, Garre M, Nuciforo PG, Bensimon A, et al. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature. 2006;444:638-642.

    Not in our library10.1038/nature05327 (opens in a new tab)

14. 14.

    Elkon R, Rashi-Elkeles S, Lerenthal Y, Linhart C, Tenne T, Amariglio N, Rechavi G, Shamir R, Shiloh Y. Dissection of a DNA-damage-induced transcriptional network using a combination of microarrays, RNA interference and computational promoter analysis. Genome Biol. 2005;6:R43.

    Not in our library10.1186/gb-2005-6-5-r43 (opens in a new tab)

15. 15.

    Gorgoulis VG, Vassiliou LV, Karakaidos P, Zacharatos P, Kotsinas A, Liloglou T, Venere M, Ditullio RA, Kastrinakis NG, Levy B, et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature. 2005;434:907-913.

    Not in our library10.1038/nature03485 (opens in a new tab)

16. 16.

    Gruhne B, Sompallae R, Marescotti D, Kamranvar SA, Gastaldello S, Masucci MG. The Epstein-Barr virus nuclear antigen-1 promotes genomic instability via induction of reactive oxygen species. Proc Natl Acad Sci U S A. 2009a;106:2313-2318.

    Not in our library10.1073/pnas.0810619106 (opens in a new tab)

17. 17.

    Gruhne B, Sompallae R, Masucci MG. Three Epstein-Barr virus latency proteins independently promote genomic instability by inducing DNA damage, inhibiting DNA repair and inactivating cell cycle checkpoints. Oncogene. 2009b;28:3997-4008.

    Not in our library10.1038/onc.2009.258 (opens in a new tab)

18. 18.

    Halazonetis TD, Gorgoulis VG, Bartek J. An oncogene-induced DNA damage model for cancer development. Science. 2008;319:1352-1355.

    Not in our library10.1126/science.1140735 (opens in a new tab)

19. 19.

    Hawkins ED, Hommel M, Turner ML, Battye FL, Markham JF, Hodgkin PD. Measuring lymphocyte proliferation, survival and differentiation using CFSE time-series data. Nat Protoc. 2007;2:2057-2067.

    Not in our library10.1038/nprot.2007.297 (opens in a new tab)

20. 20.

    Henderson E, Miller G, Robinson J, Heston L. Efficiency of transformation of lymphocytes by Epstein-Barr virus. Virology. 1977;76:152-163.

    Not in our library10.1016/0042-6822(77)90292-6 (opens in a new tab)

21. 21.

    Hertle ML, Popp C, Petermann S, Maier S, Kremmer E, Lang R, Mages J, Kempkes B. Differential gene expression patterns of EBV infected EBNA-3A positive and negative human B lymphocytes. PLoS Pathog. 2009;5:e1000506.

    Not in our library10.1371/journal.ppat.1000506 (opens in a new tab)

22. 22.

    Hickson I, Zhao Y, Richardson CJ, Green SJ, Martin NM, Orr AI, Reaper PM, Jackson SP, Curtin NJ, Smith GC. Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM. Cancer Res. 2004;64:9152-9159.

    Not in our library10.1158/0008-5472.can-04-2727 (opens in a new tab)

23. 23.

    Hong S, Pusapati RV, Powers JT, Johnson DG. Oncogenes and the DNA Damage Response: Myc and E2F1 Engage the ATM Signaling Pathway to Activate p53 and Induce Apoptosis. Cell Cycle. 2006;5.

    Not in our library10.4161/cc.5.8.2638 (opens in a new tab)

24. 24.

    Kaiser C, Laux G, Eick D, Jochner N, Bornkamm GW, Kempkes B. The proto-oncogene c-myc is a direct target gene of Epstein-Barr virus nuclear antigen 2. J Virol. 1999;73:4481-4484.

    Not in our library10.1128/jvi.73.5.4481-4484.1999 (opens in a new tab)

25. 25.

    Kalla M, Schmeinck A, Bergbauer M, Pich D, Hammerschmidt W. AP-1 homolog BZLF1 of Epstein-Barr virus has two essential functions dependent on the epigenetic state of the viral genome. Proc Natl Acad Sci U S A. 2010;107:850-855.

    Not in our library10.1073/pnas.0911948107 (opens in a new tab)

26. 26.

    Karlseder J, Broccoli D, Dai Y, Hardy S, de Lange T. p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science. 1999;283:1321-1325.

    Not in our library10.1126/science.283.5406.1321 (opens in a new tab)

27. 27.

    Kieff E, Rickinson A, Knipe DM, Howley PM. Epstein-Barr virus and its replication. Fields Virology. 2006;2603-2654.

    Not in our library

28. 28.

    Koopal S, Furuhjelm JH, Jarviluoma A, Jaamaa S, Pyakurel P, Pussinen C, Wirzenius M, Biberfeld P, Alitalo K, Laiho M, et al. Viral oncogene-induced DNA damage response is activated in Kaposi sarcoma tumorigenesis. PLoS Pathog. 2007;3:1348-1360.

    Not in our library10.1371/journal.ppat.0030140 (opens in a new tab)

29. 29.

    Kudoh A, Fujita M, Zhang L, Shirata N, Daikoku T, Sugaya Y, Isomura H, Nishiyama Y, Tsurumi T. Epstein-Barr virus lytic replication elicits ATM checkpoint signal transduction while providing an S-phase-like cellular environment. J Biol Chem. 2005;280:8156-8163.

    Not in our library10.1074/jbc.m411405200 (opens in a new tab)

30. 30.

    Lacoste S, Wiechec E, Dos Santos Silva AG, Guffei A, Williams G, Lowbeer M, Benedek K, Henriksson M, Klein G, Mai S. Chromosomal rearrangements after ex vivo Epstein-Barr virus (EBV) infection of human B cells. Oncogene. 2009.

    Not in our library10.1038/onc.2009.359 (opens in a new tab)

31. 31.

    Lilley CE, Schwartz RA, Weitzman MD. Using or abusing: viruses and the cellular DNA damage response. Trends Microbiol. 2007;15:119-126.

    Not in our library10.1016/j.tim.2007.01.003 (opens in a new tab)

32. 32.

    MacLennan IC. Germinal centers. Annu Rev Immunol. 1994;12:117-139.

    Not in our library10.1146/annurev.iy.12.040194.001001 (opens in a new tab)

33. 33.

    Mauser A, Saito S, Appella E, Anderson CW, Seaman WT, Kenney S. The Epstein-Barr virus immediate-early protein BZLF1 regulates p53 function through multiple mechanisms. J Virol. 2002;76:12503-12512.

    Not in our library10.1128/jvi.76.24.12503-12512.2002 (opens in a new tab)

34. 34.

    Murphy DJ, Junttila MR, Pouyet L, Karnezis A, Shchors K, Bui DA, Brown-Swigart L, Johnson L, Evan GI. Distinct thresholds govern Myc's biological output in vivo. Cancer Cell. 2008;14:447-457.

    Not in our library10.1016/j.ccr.2008.10.018 (opens in a new tab)

35. 35.

    Pusapati RV, Rounbehler RJ, Hong S, Powers JT, Yan M, Kiguchi K, McArthur MJ, Wong PK, Johnson DG. ATM promotes apoptosis and suppresses tumorigenesis in response to Myc. Proc Natl Acad Sci U S A. 2006;103:1446-1451.

    Not in our library10.1073/pnas.0507367103 (opens in a new tab)

36. 36.

    Ranuncolo SM, Polo JM, Dierov J, Singer M, Kuo T, Greally J, Green R, Carroll M, Melnick A. Bcl-6 mediates the germinal center B cell phenotype and lymphomagenesis through transcriptional repression of the DNA-damage sensor ATR. Nat Immunol. 2007;8:705-714.

    Not in our library10.1038/ni1478 (opens in a new tab)

37. 37.

    Roughan JE, Thorley-Lawson DA. The intersection of Epstein-Barr virus with the germinal center. J Virol. 2009;83:3968-3976.

    Not in our library10.1128/jvi.02609-08 (opens in a new tab)

38. 38.

    Schlager S, Speck SH, Woisetschlager M. Transcription of the Epstein-Barr virus nuclear antigen 1 (EBNA1) gene occurs before induction of the BCR2 (Cp) EBNA gene promoter during the initial stages of infection in B cells. J Virol. 1996;70:3561-3570.

    Not in our library10.1128/jvi.70.6.3561-3570.1996 (opens in a new tab)

39. 39.

    Siemer D, Kurth J, Lang S, Lehnerdt G, Stanelle J, Kuppers R. EBV transformation overrides gene expression patterns of B cell differentiation stages. Mol Immunol. 2008;45:3133-3141.

    Not in our library10.1016/j.molimm.2008.03.002 (opens in a new tab)

40. 40.

    Sinclair AJ, Palmero I, Peters G, Farrell PJ. EBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus. Embo J. 1994;13:3321-3328.

    Not in our library10.1002/j.1460-2075.1994.tb06634.x (opens in a new tab)

Cited by papers we hold 8

• Nasopharyngeal carcinoma ecology theory: cancer as multidimensional spatiotemporal “unity of ecology and evolution” pathological ecosystem · 2023
  No notice
• Analysis of Global Transcriptome Change in Mouse Embryonic Fibroblasts After dsDNA and dsRNA Viral Mimic Stimulation · 2019
  Not checked
• Epstein-Barr-Virus-Induced One-Carbon Metabolism Drives B Cell Transformation · 2019
  No notice
• Epstein−Barr virus-encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B-cell lymphomas · 2018
  No notice
• Recent advances in understanding Epstein-Barr virus [version 1; referees: 4 approved] · 2017
  Not checked
• Co-infection of Epstein-Barr virus and human papillomavirus in human tumorigenesis · 2016
  Not checked
• To Be or Not IIb: A Multi-Step Process for Epstein-Barr Virus Latency Establishment and Consequences for B Cell Tumorigenesis · 2015
  No notice
• The Viral and Cellular MicroRNA Targetome in Lymphoblastoid Cell Lines · 2012
  No notice

Questions about this paper

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.